药物基因组学研讨会:对实习药剂师知识和技能发展的混合方法评估,以及研讨会辅导员的需求
Emma Groves1,2, Jessica Keen3,4, Samantha L McLean5
1NHS North East and Yorkshire Genomic Medicine Service Alliance, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne NE1 3BZ, United Kingdom.
The International journal of pharmacy practice
|February 17, 2026
概括
药物基因组学 (PGx) 研讨会显著提高了英国实习药剂师的知识,但在临床应用中存在差距. 辅导员需要更好的资源来提供有效的PGx培训,特别是在线培训.
科学领域:
- 药物基因组学 教育 教育 药物基因组学
- 药房实践研究研究 药房实践研究
- 医疗保健专业培训 医疗保健专业培训
背景情况:
- 将药物基因组学 (PGx) 纳入临床实践对于个性化医学至关重要.
- 需要有效的培训策略来为药剂师提供PGx知识和技能.
- 了解教育干预措施对实习药剂师的影响至关重要.
研究的目的:
- 评估药物基因组学 (PGx) 研讨会对英国实习药剂师知识,信心和临床应用的影响.
- 探索研讨会主持人的经验和支持要求.
- 确定PGx教育提供需要改进的领域.
主要方法:
- 混合方法研究,涉及研讨会前后对参与者的调查.
- 专注小组与研讨会主持人一起进行,以收集定性见解.
- 使用描述性统计和配对t测试分析定量数据;用主题分析定性数据.
主要成果:
- 实习药剂师自我报告的PGx知识显著增加 (P < .01).
- 增加了对应用PGx的信心,尽管在统计学上并不显著 (P = .06).
- 促进者注意到参与 (特别是在线) 的挑战,并要求提供更好的准备材料和支持.
结论:
- PGx研讨会有效地提高了实习药剂师的知识,但强调了临床应用中的持续差距.
- 促进者反强调了需要加强培训资源和支持的需要,特别是在线交付.
- 建议进行代培训和补充材料,以巩固PGx知识及其实际应用.
更多相关视频
相关概念视频
Pharmacogenetics and Pharmacogenomics: Overview
20
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
20
Pharmacogenomics: Identification of New Drug Targets
20
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
20
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
18
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
18
Pharmacogenetics of Drug Metabolism: Overview
23
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
23
Principles of Pharmacogenetics: Types of Genetic Variants
22
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
22
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
24
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
24


